乐鱼在线

Reliable Quality

Affordable Innovation

Name	Indication	Clinical Trial Phase	Study Title
HLX02	Healthy Male Subjects	Phase I	A Study of Safety and Tolerability of HLX02 with Different Dose and a Phase I Study Comparing HLX02 and Herceptin^®(U.S. and German)
HLX02	BC	Phase III	A Phase III Study Comparing the Safety and Efficacy of HLX02 and Herceptin^®(U.S. and German) in Breast Cancer
HLX01	CD20-Positive B-cell Lymphomas	Phase Ia	A Phase Ia Study to Evaluate Safety, Tolerability, PK and PD of HLX01 in Patients with CD20-positive B-cell Lymphomas
HLX01	CD20-positive B-cell Lymphomas	Phase I	A Pharmacokinetic and Pharmacodynamic Study Comparing HLX01 and Rituximab
HLX01	DLBCL	Phase III	Clinical Study to Compare the Efficacy and Safety of Rituximab Biosimilar HLX01 in Combination with CHOP and Rituximab in Combination with CHOP

var _hmt = _hmt || []; (function() { var hm = document.createElement("script"); hm.src = "https://hm.baidu.com/hm.js?90c4d9819bca8c9bf01e7898dd269864"; var s = document.getElementsByTagName("script")[0]; s.parentNode.insertBefore(hm, s); })(); !function(p){"use strict";!function(t){var s=window,e=document,i=p,c="".concat("https:"===e.location.protocol?"https://":"http://","sdk.51.la/js-sdk-pro.min.js"),n=e.createElement("script"),r=e.getElementsByTagName("script")[0];n.type="text/javascript",n.setAttribute("charset","UTF-8"),n.async=!0,n.src=c,n.id="LA_COLLECT",i.d=n;var o=function(){s.LA.ids.push(i)};s.LA?s.LA.ids&&o():(s.LA=p,s.LA.ids=[],o()),r.parentNode.insertBefore(n,r)}()}({id:"K9y7iMpaU8NS42Fm",ck:"K9y7iMpaU8NS42Fm"}); 乐鱼在线官网-乐鱼在线 ufc下注官网_ufc竞猜平台【新版本下载】 ufc下注_ufc押注网站 ufc下注官网_ufc竞猜软件【注册登录】天博APP-天博APP下载-天博APP官方网站